Your browser doesn't support javascript.
loading
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results
Colleen McLaughlin; Margaret K. Doll; Kathryn T Morrison; William L McLaughlin III; Terry OConnor; Anton M Sholukh; Emily L Bossard; Khamsone Phasouk; Emily S Ford; Kurt Diem; Alexis M Hlock; Keith R Jerome; Lawrence Corey.
Afiliación
  • Colleen McLaughlin; Albany College of Pharmacy and Health Sciences
  • Margaret K. Doll; Albany College of Pharmacy and Health Sciences
  • Kathryn T Morrison; Precision Analytics, Montreal, Quebec, Canada; McGill University, Montreal, Quebec, Canada
  • William L McLaughlin III; City of Ketchum Fire Department
  • Terry OConnor; Blaine County Ambulance District. University of Colorado School of Medicine, section Wilderness and Environmental Medicine. University of Washington Department
  • Anton M Sholukh; Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
  • Emily L Bossard; Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
  • Khamsone Phasouk; Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
  • Emily S Ford; Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA; Division of Allergy and Infectious Diseases, Department of Medicine, Un
  • Kurt Diem; Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA
  • Alexis M Hlock; Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA
  • Keith R Jerome; Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA; Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Cent
  • Lawrence Corey; Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA; Division of Allergy and Infectious Diseases, Department of Medicine, Un
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-20157198
ABSTRACT
Community-level seroprevalence surveys are needed to determine the proportion of the population with previous SARS-CoV-2 infection, a necessary component of COVID-19 disease surveillance. In May, 2020, we conducted a cross-sectional seroprevalence study of IgG antibodies for nucleocapsid of SARS-CoV-2 among the residents of Blaine County, Idaho, a ski resort community with high COVID-19 attack rates in late March and Early April (2.9% for ages 18 and older). Participants were selected from volunteers who registered via a secure web link, using prestratification weighting to the population distribution by age and gender within each ZIP Code. Participants completed a survey reporting their demographics and symptoms; 88% of volunteers who were invited to participate completed data collection survey and had 10 ml of blood drawn. Serology was completed via the Abbott Architect SARS-CoV-2 IgG immunoassay. Primary analyses estimated seroprevalence and 95% credible intervals (CI) using a hierarchical Bayesian framework to account for diagnostic uncertainty. Stratified models were run by age, sex, ZIP Code, ethnicity, employment status, and a priori participant-reported COVID-19 status. Sensitivity analyses to estimate seroprevalence included base models with post-stratification for ethnicity, age, and sex, with or without adjustment for multi-participant households. IgG antibodies to the virus that causes COVID-19 were found among 22.7% (95% CI 20.1%, 25.5%) of residents of Blaine County. Higher levels of antibodies were found among residents of the City of Ketchum 34.8% (95% CI 29.3%, 40.5%), compared to Hailey 16.8% (95%CI 13.7%, 20.3%) and Sun Valley 19.4% (95% 11.8%, 28.4%). People who self-identified as not believing they had COVID-19 had the lowest prevalence 4.8% (95% CI 2.3%, 8.2%). The range of seroprevalence after correction for potential selection bias was 21.9% to 24.2%. This study suggests more than 80% of SARS-CoV-2 infections were not reported. Although Blaine County had high levels of SARS-CoV-2 infection, the community is not yet near the herd immunity threshold.
Licencia
cc_by_nc_nd
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Observational_studies / Rct Idioma: En Año: 2020 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Observational_studies / Rct Idioma: En Año: 2020 Tipo del documento: Preprint